Clinical Trials Logo

Lumbago clinical trials

View clinical trials related to Lumbago.

Filter by:

NCT ID: NCT01835795 Completed - Low Back Pain Clinical Trials

Radial Extracorporeal Shock Wave Treatment (rESWT) of Myofascial Pain Syndrome in Low Back Pain

Start date: January 7, 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of treatment of radial shockwave in myofascial pain syndrome in the lumbar region compared to placebo through questionnaires and imaging exams.

NCT ID: NCT01694134 Completed - Low Back Pain Clinical Trials

Assessment of the Efficacy of an Intradiscal Injection of Corticoids in Modic I Discopathies.

MODISC
Start date: July 12, 2012
Phase: Phase 3
Study type: Interventional

The treatment of chronic low back pain is a major objective of public healthcare, because it causes an important number of sick leaves. A correlation between clinical observations and an inflammatory discopathy has been underlined, but there is currently any reference treatment. In this study, the main objective is to assess the efficacy of an intradiscal injection of corticoids versus local anaesthetic on the treatment of pain of patients with low back pain associated to a Modic I discopathy.

NCT ID: NCT01155804 Recruiting - Anxiety Clinical Trials

Assessment of the Effectiveness of a Program of Preparation to Pregnancy and Delivery

Start date: June 2009
Phase: Phase 4
Study type: Interventional

Introduction: randomized studies on programs implemented during pre-natal care that offer information and physical activities preparing pregnant women for delivery are scarce in the scientific literature. Objective: to evaluate the effectively of the Program for Preparation of Pregnant Women for Delivery on the prevention of physical and psychological difficulties and problems during pregnancy and delivery in nulliparous women participating in the program. Subjects and methods: a randomized clinical single blind trial will be conducted with 192 pregnant nulliparous women allocated to participate or not of the program activities. The women allocated to the study group will participate of physical and educational activities at each pre-natal consultation and will receive orientation on the exercises they will perform at their home. Participants of the non-interventional group will follow the habitual routine care at the service. Participants will be selected among nulliparous low risk pregnant women aged between 16 and 40 years old after the 20th week of gestation. Data analysis: will be performing by intention to treat. For the continues variables the t-Student or Wilcoxon test will be performing; for the categorical variables the tests x² or Fisher, and the risk estimate will be estimated using a Relative Risk with 95% CI. ANOVA will be use for measures between the groups and along time, and correlation tests for anxiety and physical activity with gestational and perinatal variables.

NCT ID: NCT00922428 Completed - Rheumatic Diseases Clinical Trials

PASCOE-Agil HOM-Injektopas in the Treatment of Rheumatic Disorders

157
Start date: January 2009
Phase: N/A
Study type: Observational

The purpose of this observational study is to give an overview of the use of PASCOE-Agil HOM-Injektopas in a 2-4 week treatment of rheumatic disorders.

NCT ID: NCT00595517 Completed - Clinical trials for Rheumatoid Arthritis

Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer

Start date: October 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the Safety and tolerability of D961H (Esomeprazole) 20 mg once daily for up to 52 weeks of treatment involving patients with a history of gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID) therapy by evaluating AE, clinical laboratory value and vital signs.

NCT ID: NCT00542789 Completed - Clinical trials for Rheumatoid Arthritis

Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID

Start date: August 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the efficacy of esomeprazole (D961H) 20 mg versus placebo once daily for up to 24 weeks of treatment involving patients with a history of gastric and/or duodenal ulcers receiving daily nonsteroidal anti-inflammatory drug (NSAID) therapy by evaluating presence or absence of gastric and/or duodenal ulcers throughout the treatment period (24 weeks) in terms of efficacy on prevention of gastric and/or duodenal ulcers